Actelion Ltd. (ALIOF.PK) Shareholders Reject Executive Pay Plan
4/19/2013 8:18:19 AM
More...
|
Federal Trade Commission Slams Actelion Pharmaceuticals US, Inc. (ATLN.VX) for Withholding Samples
3/13/2013 7:31:02 AM
More...
|
Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Announce Approval of XIAFLEX® In Canada
7/9/2012 7:31:48 AM
More...
|
FDA Approves Actelion Pharmaceuticals US, Inc. (ATLN.VX)'s SNDA for Second Generation VELETRI for Injection
6/29/2012 7:06:20 AM
More...
|
Auxilium Pharmaceuticals (AUXL) and Actelion Pharmaceuticals US, Inc. (ATLN.VX) Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico for Up to $68.5 Million
2/23/2012 7:39:59 AM
More...
|
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Floods FDA With Patient Death Reports
10/6/2011 7:50:51 AM
More...
|
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Release: Pulmonary Hypertension Association Names Dr. Ronald Oudiz Recipient of 2011 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
5/18/2011 9:03:06 AM
More...
|
Updated U.S. Product Labeling for Actelion Ltd. (ALIOF.PK)'s Veletri (Epoprostenol for Injection) Allows Patients to Prepare This Medication Up to a Week in Advance of Use for Pulmonary Arterial Hypertension
10/5/2010 11:43:22 AM
More...
|
Actelion Pharmaceuticals US, Inc. (ATLN.VX) Pays Eur 10 Million for Option to Buy Trophos for up to Eur 195 Million
7/20/2010 12:21:56 PM
More...
|
Pulmonary Hypertension Association Names Actelion Pharmaceuticals US, Inc. (ATLN.VX) Recipient of 2010 Corporation of the Year Award
6/28/2010 10:01:21 AM
More...
|
|